784 related articles for article (PubMed ID: 34730204)
1. Comparison between use of direct oral anticoagulants and aspirin for risk of thromboembolism complications in patients undergoing total knee and hip arthroplasty: a systematic review and meta-analysis.
Cai JY; Cui CM; Min JK; Cao YQ; Zhang LY
Eur Rev Med Pharmacol Sci; 2021 Oct; 25(20):6245-6259. PubMed ID: 34730204
[TBL] [Abstract][Full Text] [Related]
2. Aspirin or Rivaroxaban for VTE Prophylaxis after Hip or Knee Arthroplasty.
Anderson DR; Dunbar M; Murnaghan J; Kahn SR; Gross P; Forsythe M; Pelet S; Fisher W; Belzile E; Dolan S; Crowther M; Bohm E; MacDonald SJ; Gofton W; Kim P; Zukor D; Pleasance S; Andreou P; Doucette S; Theriault C; Abianui A; Carrier M; Kovacs MJ; Rodger MA; Coyle D; Wells PS; Vendittoli PA
N Engl J Med; 2018 Feb; 378(8):699-707. PubMed ID: 29466159
[TBL] [Abstract][Full Text] [Related]
3. Clinical Effectiveness and Safety of Aspirin for Venous Thromboembolism Prophylaxis After Total Hip and Knee Replacement: A Systematic Review and Meta-analysis of Randomized Clinical Trials.
Matharu GS; Kunutsor SK; Judge A; Blom AW; Whitehouse MR
JAMA Intern Med; 2020 Mar; 180(3):376-384. PubMed ID: 32011647
[TBL] [Abstract][Full Text] [Related]
4. Aspirin Compared with Anticoagulation to Prevent Venous Thromboembolism After Knee or Hip Arthroplasty: a Large Retrospective Cohort Study.
Baumgartner C; Maselli J; Auerbach AD; Fang MC
J Gen Intern Med; 2019 Oct; 34(10):2038-2046. PubMed ID: 31236894
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of aspirin and rivaroxaban for venous thromboembolism prophylaxis after total hip or knee arthroplasty: A protocol for meta-analysis.
Le G; Yang C; Zhang M; Xi L; Luo H; Tang J; Zhao J
Medicine (Baltimore); 2020 Dec; 99(49):e23055. PubMed ID: 33285683
[TBL] [Abstract][Full Text] [Related]
6. Oral direct factor Xa inhibitor versus enoxaparin for thromboprophylaxis after hip or knee arthroplasty: Systemic review, traditional meta-analysis, dose-response meta-analysis and network meta-analysis.
Feng W; Wu K; Liu Z; Kong G; Deng Z; Chen S; Wu Y; Chen M; Liu S; Wang H
Thromb Res; 2015 Dec; 136(6):1133-44. PubMed ID: 26498222
[TBL] [Abstract][Full Text] [Related]
7. Comparative effectiveness of new oral anticoagulants and standard thromboprophylaxis in patients having total hip or knee replacement: a systematic review.
Adam SS; McDuffie JR; Lachiewicz PF; Ortel TL; Williams JW
Ann Intern Med; 2013 Aug; 159(4):275-84. PubMed ID: 24026260
[TBL] [Abstract][Full Text] [Related]
8. Oral direct Factor Xa inhibitors versus low-molecular-weight heparin to prevent venous thromboembolism in patients undergoing total hip or knee replacement: a systematic review and meta-analysis.
Neumann I; Rada G; Claro JC; Carrasco-Labra A; Thorlund K; Akl EA; Bates SM; Guyatt GH
Ann Intern Med; 2012 May; 156(10):710-9. PubMed ID: 22412038
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and safety of rivaroxaban for the prevention of thrombosis following total hip or knee replacement: A systematic review and meta-analysis.
Liu J; Zhao J; Yan Y; Su J
Medicine (Baltimore); 2019 Mar; 98(9):e14539. PubMed ID: 30817570
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of new oral anticoagulants and low-molecular-weight heparins compared with aspirin in patients undergoing total knee and hip replacements.
Nielen JT; Dagnelie PC; Emans PJ; Veldhorst-Janssen N; Lalmohamed A; van Staa TP; Boonen AE; van den Bemt BJ; de Vries F
Pharmacoepidemiol Drug Saf; 2016 Nov; 25(11):1245-1252. PubMed ID: 27594378
[TBL] [Abstract][Full Text] [Related]
11. The risk of venous thromboembolism with aspirin compared to anticoagulants after hip and knee arthroplasty.
Chu JN; Maselli J; Auerbach AD; Fang MC
Thromb Res; 2017 Jul; 155():65-71. PubMed ID: 28501678
[TBL] [Abstract][Full Text] [Related]
12. Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty: The FOXTROT Randomized Clinical Trial.
Weitz JI; Bauersachs R; Becker B; Berkowitz SD; Freitas MCS; Lassen MR; Metzig C; Raskob GE
JAMA; 2020 Jan; 323(2):130-139. PubMed ID: 31935028
[TBL] [Abstract][Full Text] [Related]
13. Aspirin compared to enoxaparin or rivaroxaban for thromboprophylaxis following hip and knee replacement.
Ní Cheallaigh S; Fleming A; Dahly D; Kehoe E; O'Byrne JM; McGrath B; O'Connell C; Sahm LJ
Int J Clin Pharm; 2020 Jun; 42(3):853-860. PubMed ID: 32328957
[TBL] [Abstract][Full Text] [Related]
14. Comparative effectiveness of venous thromboembolism prophylaxis options for the patient undergoing total hip and knee replacement: a network meta-analysis.
Kapoor A; Ellis A; Shaffer N; Gurwitz J; Chandramohan A; Saulino J; Ishak A; Okubanjo T; Michota F; Hylek E; Trikalinos TA
J Thromb Haemost; 2017 Feb; 15(2):284-294. PubMed ID: 28102615
[TBL] [Abstract][Full Text] [Related]
15. Ranking the efficacy of anticoagulants for the prevention of venous thromboembolism after total hip or knee arthroplasty: A systematic review and a network meta-analysis.
Feng W; Wang X; Huang D; Lu A
Pharmacol Res; 2021 Apr; 166():105438. PubMed ID: 33540046
[TBL] [Abstract][Full Text] [Related]
16. Incidence of symptomatic venous thromboembolism in 2372 knee and hip replacement patients after discharge: data from a thromboprophylaxis registry in Montreal, Canada.
Senay A; Trottier M; Delisle J; Banica A; Benoit B; Laflamme GY; Malo M; Nguyen H; Ranger P; Fernandes JC
Vasc Health Risk Manag; 2018; 14():81-89. PubMed ID: 29780248
[TBL] [Abstract][Full Text] [Related]
17. Is Aspirin as Effective as the Newer Direct Oral Anticoagulants for Venous Thromboembolism Prophylaxis After Total Hip and Knee Arthroplasty? An Analysis From the National Joint Registry for England, Wales, Northern Ireland, and the Isle of Man.
Matharu GS; Garriga C; Whitehouse MR; Rangan A; Judge A
J Arthroplasty; 2020 Sep; 35(9):2631-2639.e6. PubMed ID: 32532481
[TBL] [Abstract][Full Text] [Related]
18. Aspirin Can Be Used as Prophylaxis for Prevention of Venous Thromboembolism After Revision Hip and Knee Arthroplasty.
Deirmengian GK; Heller S; Smith EB; Maltenfort M; Chen AF; Parvizi J
J Arthroplasty; 2016 Oct; 31(10):2237-40. PubMed ID: 27118182
[TBL] [Abstract][Full Text] [Related]
19. Direct factor Xa inhibitors (rivaroxaban and apixaban) versus enoxaparin for the prevention of venous thromboembolism after total knee replacement: A meta-analysis of 6 randomized clinical trials.
Ma G; Zhang R; Wu X; Wang D; Ying K
Thromb Res; 2015 May; 135(5):816-22. PubMed ID: 25728496
[TBL] [Abstract][Full Text] [Related]
20. Aspirin as Thromboprophylaxis in Hip and Knee Arthroplasty: A Systematic Review and Meta-Analysis.
An VV; Phan K; Levy YD; Bruce WJ
J Arthroplasty; 2016 Nov; 31(11):2608-2616. PubMed ID: 27178011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
